Urological Cancer Therapeutics Drugs Market Report

Global and China Urological Cancer Therapeutics Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 09, 2022
  • PAGES：204
  • REPORT CODE：GMM1448075
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Urological Cancer Therapeutics Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Johnson & Johnson

    • Bristol-Myers Squibb

    • GlaxoSmithKline plc

    • Ferring Pharmaceuticals

    • Dendreon Corporation

    • AstraZeneca

    • Roche Healthcare

    • Astellas

    • Abbott Laboratories

    • Novartis

    • Indevus Pharmaceuticals Inc

    • Pfizer

    • Ipsen

    • Sanofi SA

    • Celgene Corporation

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Xofigo

    • Jevtana

    • Inlyta

    • Votrient

    • Sutent

    • Zytiga

    • Xtandi

    • Opdivo

    • Provenge

    Application:

    • Hospital

    • Medical Research Laboratory

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Urological Cancer Therapeutics Drugs Industry Overview

      • 1.1.1 Urological Cancer Therapeutics Drugs Market Scope and Market Segments

      • 1.1.2 Urological Cancer Therapeutics Drugs Industry Characteristics

      • 1.1.3 Global and China Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Urological Cancer Therapeutics Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Xofigo

      • 1.2.2 Jevtana

      • 1.2.3 Inlyta

      • 1.2.4 Votrient

      • 1.2.5 Sutent

      • 1.2.6 Zytiga

      • 1.2.7 Xtandi

      • 1.2.8 Opdivo

      • 1.2.9 Provenge

    • 1.3 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Medical Research Laboratory

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Urological Cancer Therapeutics Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Urological Cancer Therapeutics Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Urological Cancer Therapeutics Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Urological Cancer Therapeutics Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Urological Cancer Therapeutics Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Urological Cancer Therapeutics Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Urological Cancer Therapeutics Drugs Industry PEST Analysis

    • 2.3 Urological Cancer Therapeutics Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Urological Cancer Therapeutics Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Urological Cancer Therapeutics Drugs Industry

    Chapter 3 Global and China Urological Cancer Therapeutics Drugs Market, by Manufacturer

    • 3.1 Global and China Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Urological Cancer Therapeutics Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Urological Cancer Therapeutics Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Urological Cancer Therapeutics Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Urological Cancer Therapeutics Drugs Market Top 3 Players

    Chapter 4 Global and China Urological Cancer Therapeutics Drugs Market, by Type (2017-2028)

    • 4.1 Urological Cancer Therapeutics Drugs Market Trend, by Type

    • 4.2 Global Urological Cancer Therapeutics Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Urological Cancer Therapeutics Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Urological Cancer Therapeutics Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Urological Cancer Therapeutics Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Urological Cancer Therapeutics Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Urological Cancer Therapeutics Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Urological Cancer Therapeutics Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Urological Cancer Therapeutics Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Urological Cancer Therapeutics Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Urological Cancer Therapeutics Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Urological Cancer Therapeutics Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Urological Cancer Therapeutics Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Urological Cancer Therapeutics Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Urological Cancer Therapeutics Drugs Market Analysis

    • 7.1 North America Urological Cancer Therapeutics Drugs Market, by Type

    • 7.2 North America Urological Cancer Therapeutics Drugs Market, by Application

    • 7.3 North America Urological Cancer Therapeutics Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Urological Cancer Therapeutics Drugs Market Analysis

    • 8.1 Europe Urological Cancer Therapeutics Drugs Market, by Type

    • 8.2 Europe Urological Cancer Therapeutics Drugs Market, by Application

    • 8.3 Europe Urological Cancer Therapeutics Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Urological Cancer Therapeutics Drugs Market Analysis

    • 9.1 APAC Urological Cancer Therapeutics Drugs Market, by Type

    • 9.2 APAC Urological Cancer Therapeutics Drugs Market, by Application

    • 9.3 APAC Urological Cancer Therapeutics Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Urological Cancer Therapeutics Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Urological Cancer Therapeutics Drugs Company Profiles

      • 11.1 Johnson & Johnson

        • 11.1.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Johnson & Johnson Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.1.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Bristol-Myers Squibb

        • 11.2.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.2.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 GlaxoSmithKline plc

        • 11.3.1 GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.3.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Ferring Pharmaceuticals

        • 11.4.1 Ferring Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.4.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Dendreon Corporation

        • 11.5.1 Dendreon Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Dendreon Corporation Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.5.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 AstraZeneca

        • 11.6.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 AstraZeneca Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.6.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Roche Healthcare

        • 11.7.1 Roche Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Roche Healthcare Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.7.3 Roche Healthcare Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Astellas

        • 11.8.1 Astellas Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Astellas Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.8.3 Astellas Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Abbott Laboratories

        • 11.9.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Abbott Laboratories Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.9.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Novartis

        • 11.10.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Novartis Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.10.3 Novartis Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Indevus Pharmaceuticals Inc

        • 11.11.1 Indevus Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.11.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Pfizer

        • 11.12.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Pfizer Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.12.3 Pfizer Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Ipsen

        • 11.13.1 Ipsen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Ipsen Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.13.3 Ipsen Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Sanofi SA

        • 11.14.1 Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Sanofi SA Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.14.3 Sanofi SA Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Celgene Corporation

        • 11.15.1 Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Celgene Corporation Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

        • 11.15.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Urological Cancer Therapeutics Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Urological Cancer Therapeutics Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Urological Cancer Therapeutics Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xofigo (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Jevtana (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Inlyta (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Votrient (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Sutent (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Zytiga (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xtandi (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Opdivo (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Provenge (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Medical Research Laboratory (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Urological Cancer Therapeutics Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Urological Cancer Therapeutics Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Urological Cancer Therapeutics Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Urological Cancer Therapeutics Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Urological Cancer Therapeutics Drugs Market Share, by Manufacturer in 2022

    • Table Global Urological Cancer Therapeutics Drugs Sales Volume, by Type (2017-2028)

    • Table Global Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Urological Cancer Therapeutics Drugs Sales Value, by Type (2017-2028)

    • Table Global Urological Cancer Therapeutics Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Price Trend, by Type (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Volume, by Type (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Value, by Type (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Price Trend, by Type (2017-2028)

    • Table Global Urological Cancer Therapeutics Drugs Sales Volume, by Application (2017-2028)

    • Table Global Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Urological Cancer Therapeutics Drugs Sales Value, by Application (2017-2028)

    • Table Global Urological Cancer Therapeutics Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Urological Cancer Therapeutics Drugs Sales Value Share, by Application (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Volume, by Application (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Value, by Application (2017-2028)

    • Table China Urological Cancer Therapeutics Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Urological Cancer Therapeutics Drugs Sales Volume, by Type (2017-2028)

    • Table North America Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Urological Cancer Therapeutics Drugs Sales Volume, by Application (2017-2028)

    • Table North America Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Urological Cancer Therapeutics Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Urological Cancer Therapeutics Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Urological Cancer Therapeutics Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Urological Cancer Therapeutics Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Urological Cancer Therapeutics Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Urological Cancer Therapeutics Drugs Sales Value and Growth Rate (2017-2028)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ferring Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ferring Pharmaceuticals Product Profiles, Application and Specification

    • Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dendreon Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dendreon Corporation Product Profiles, Application and Specification

    • Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Healthcare Product Profiles, Application and Specification

    • Table Roche Healthcare Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Product Profiles, Application and Specification

    • Table Astellas Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Indevus Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Indevus Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ipsen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ipsen Product Profiles, Application and Specification

    • Table Ipsen Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi SA Product Profiles, Application and Specification

    • Table Sanofi SA Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Corporation Product Profiles, Application and Specification

    • Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US